M ehta and colleagues 1 performed a randomized controlled trial of the impact on inadequately controlled blood pressures of two technological interventions to improve medication adherence. [2] [3] [4] They compared usual care to electronic pill bottles that notified the study's electronic platform when the patients opened them and to bidirectional text messaging from the platform that asked the patients to text back if they took the medication. The patients of both intervention groups received messages each day reporting on the previous day and reminding them to take their medications. Neither intervention lowered systolic blood pressures at 4 months more than did usual care.
Why the lack of impact? The authors provide four possible answers. First, the problem may not have been adherence, but lack of appropriate dose escalation. Second, the improvements in adherence, if they occurred, may not have been enough to show improvement. Third, the patient population, mostly African-Americans in clinics with a considerable focus already on blood pressure control, may have had particularly resistant hypertension. Fourth, the effect may have been masked by the improvement in the control group, as a result of regression to the mean, of participating in a study, with its financial incentives to participate and return for followup, or of taking their medications merely for the followup visit.
The additional possibility is that these technological interventions do not work very well. Indeed, there was no difference between arms in self-reported adherence at the end of the study. In addition, the measured adherences of 70.8% with electronic pill bottles and 77.0% with bidirectional texting were the rates only of opening the bottle or sending a text response, not actually of taking the pill. Furthermore, Mehta and colleagues are not alone in achieving apparent improvements in adherence but not in clinical outcomes. 2, 5 What to do? While the participants' high recommendations of both technologies (9 out of 10) should encourage us not to abandon technology, the answer to improving blood pressure control is likely to be more intensive interactions between patients and clinicians.
